Skip to main content
OpenTrials

Clinical trial condition

Carcinoma, Bronchogenic

Explore clinical trials studying Carcinoma, Bronchogenic. Study availability and eligibility vary by location and protocol.

5,244 public trials 1,186 recruiting studies
Refine in advanced search Browse all conditions

Carcinoma, Bronchogenic trial results

Completed

A Study of MDX-1106 in Patients With Selected Refractory or Relapsed Malignancies

NCT00441337

Conditions
Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +52 more
Locations
  • Johns Hopkins Unv., School of Medicine Baltimore, Maryland, United States
  • Henry Ford Health System Detroit, Michigan, United States
  • Washington University School of Medicine - Barnes Jewish Hospital St Louis, Missouri, United States
  • Carolina BioOncology Institute, PLLC Huntersville, North Carolina, United States
View Trial Details
Completed

A Phase II Study of Doxorubicin, Cyclophosphamide and Vindesine With Valproic Acid in Patients With Refractory or Relapsing Small Cell Lung Cancer After Platinum Derivatives and Etoposide

NCT00759824

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Lung Diseases, +7 more
Locations
  • Department of Intensive Care Unit and Thoracic Oncology Institut Jules Bordet Brussels, Belgium
  • Department of Pneumology CHU Charleroi Charleroi, Belgium
  • Department of Pneumology Hôpital Saint-Joseph Gilly, Belgium
  • Hôpital Ambroise Paré Mons, Belgium
View Trial Details
Completed

Randomized Study of Cisplatin-Etoposide Versus an Etoposide Regimen Without Cisplatin in Extensive Small-Cell Lung Cancer

NCT00658580

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Lung Diseases, +8 more
Locations
  • Department of Intensive Care Unit and Thoracic Oncology Institut Jules Bordet Brussels, Belgium
  • Department of Pneumology CHRU Lille Lille, France
  • Hellenic Cancer Institute - St Savas Oncology Hospital Athens, Greece
  • Medical Oncology Hospital de Sagunto Valencia, Spain
View Trial Details
Completed

A Study of Tarceva (Erlotinib) Following Platinum-Based Chemotherapy in Patients With Advanced, Recurrent, or Metastatic Non-Small Cell Lung Cancer (NSCLC)

NCT00556712

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • St Leonards, New South Wales, Australia
  • Waratah, New South Wales, Australia
  • Brisbane, Queensland, Australia
  • Adelaide, South Australia, Australia
View all 133 locations
View Trial Details
Completed

A Safety and Efficacy Study of Carboplatin, Paclitaxel, Bevacizumab and CA4P in Non-Small Cell Lung Cancer

NCT00653939

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Southbay Oncology Hematology Campbell, California, United States
  • Pacific Coast Hematology and Oncology Medical Group Fountain Valley, California, United States
  • UCLA Division of Hematology and Oncology Los Angeles, California, United States
  • Bay Area Cancer Research Group, LLC Pleasant Hill, California, United States
View all 15 locations
View Trial Details
Completed

S9925: Collecting and Storing Samples From Patients With Lung Cancer

NCT00920010

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +9 more
Locations
  • Providence Cancer Center at Providence Hospital Mobile, Alabama, United States
  • Alaska Regional Hospital Cancer Center Anchorage, Alaska, United States
  • Providence Cancer Center Anchorage, Alaska, United States
  • Arizona Cancer Center at University of Arizona Health Sciences Center Tucson, Arizona, United States
View all 431 locations
View Trial Details

Related conditions